prevention, diagnosis and management of COVID‐19 in the IBD patient

AH Al‐Ani, RE Prentice, CA Rentsch… - Alimentary …, 2020 - Wiley Online Library
Background The current COVID‐19 pandemic, caused by SARS‐CoV‐2, has emerged as a
public health emergency. All nations are seriously challenged as the virus spreads rapidly …

A review of juvenile polyposis syndrome

E Chow, F Macrae - Journal of gastroenterology and …, 2005 - Wiley Online Library
Abstract Juvenile Polyposis Syndrome is an uncommon hamartomatous disorder with
significant gastrointestinal malignant potential. Mutations in SMAD4 and BMPR1A …

[HTML][HTML] Celecoxib for the prevention of sporadic colorectal adenomas

MM Bertagnolli, CJ Eagle, AG Zauber… - … England Journal of …, 2006 - Mass Medical Soc
Background Studies showing that drugs that inhibit cyclooxygenase-2 (COX-2) reduce the
number of colorectal adenomas in animals and patients with familial adenomatous …

[HTML][HTML] Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein… - The Lancet, 2011 - thelancet.com
Background Observational studies report reduced colorectal cancer in regular aspirin
consumers. Randomised controlled trials have shown reduced risk of adenomas but none …

[HTML][HTML] Update on hereditary colorectal cancer: improving the clinical utility of multigene panel testing

M Lorans, E Dow, FA Macrae, IM Winship… - Clinical colorectal …, 2018 - Elsevier
Colorectal cancer (CRC), one of the most common cancers, is a major public health issue
globally, especially in Westernized countries. Up to 35% of CRCs are thought to be due to …

Crohn's disease management after intestinal resection: a randomised trial

P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie… - The Lancet, 2015 - thelancet.com
Summary Background Most patients with Crohn's disease need an intestinal resection, but a
majority will subsequently experience disease recurrence and require further surgery. This …

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

P Møller, TT Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2018 - gut.bmj.com
Background Most patients with path_MMR gene variants (Lynch syndrome (LS)) now
survive both their first and subsequent cancers, resulting in a growing number of older …

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome …

P Møller, T Seppälä, I Bernstein, E Holinski-Feder… - Gut, 2017 - gut.bmj.com
Objective Estimates of cancer risk and the effects of surveillance in Lynch syndrome have
been subject to bias, partly through reliance on retrospective studies. We sought to establish …

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

BA Thompson, AB Spurdle, JP Plazzer, MS Greenblatt… - Nature …, 2014 - nature.com
The clinical classification of hereditary sequence variants identified in disease-related genes
directly affects clinical management of patients and their relatives. The International Society …

[HTML][HTML] Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

M Dominguez-Valentin, JR Sampson, TT Seppälä… - Genetics in …, 2020 - nature.com
Purpose Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch
syndrome and result in different but imprecisely known cancer risks. This study aimed to …